Stock RCHA RICH PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Rich Pharmaceuticals, Inc.

Equities

RCHA

US76303T4076

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
RICH PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
Rich Pharmaceuticals, Inc. Announces Board Changes
CI
Rich Pharmaceuticals, Inc. Announces Executive Changes
CI
Geopulse Exploration, Inc. cancelled the acquisition of unknown stake in Rich Pharmaceuticals, Inc..
CI
Geopulse Exploration, Inc. signed an agreement to acquire unknown stake in Rich Pharmaceuticals, Inc..
CI
Rich Pharmaceuticals, Inc. announced that it has received $0.0515 million in funding from GHS Investments, LLC
CI
Rich Pharmaceuticals, Inc Announces Study Drug RP-323 Is A Potential Therapeutic Agent for the Treatment of Hodgkin's Lymphoma
CI
Rich Pharmaceuticals, Inc. announced that it has received CNY 0.06 million in funding from GHS Investments, LLC
CI
Rich Pharmaceuticals, Inc. announced that it has received $0.03 million in funding from GHS Investments, LLC
CI
Rich Pharmaceuticals, Inc. announced that it has received $0.1 million in funding
CI
Rich Pharmaceuticals, Inc. Enters into Support and Collaboration Agreement with Mega Bridge, Inc
CI
Rich Pharmaceuticals, Inc. will Change its Ticker to RCHA.D from RCHA
CI
Rich Pharmaceuticals, Inc. announced that it has received $0.025 million in funding from GHS Investments, LLC
CI
Rich Pharmaceuticals, Inc. Appoints Carole A. Salvador as Director
CI
Rich Pharmaceuticals, Inc.'s New Division Canncodex Appoints Justin Braune as Member of the Canncodex Advisory Board
CI
Rich Pharmaceuticals, Inc. Reaches Agreement with I Tech Health Corp. to Form a Subsidiary and Launch CannCodex
CI
Rich Pharmaceuticals, Inc. announced that it has received $0.3 million in funding from GHS Investments, LLC
CI
Rich Pharmaceuticals, Inc. announced that it expects to receive $0.03 million in funding from LG Capital Funding, LLC
CI
Rich Pharmaceuticals, Inc. announced that it has received $0.112 million in funding from LG Capital Funding, LLC
CI
Rich Pharmaceuticals Agrees Additional Contract with Theradex Systems
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RCHA Stock
  4. News Rich Pharmaceuticals, Inc.